THE EFFECTS OF KANGXUAN GRANULE ON ENDOCRINE HYPERTENSIVE MODEL RATS
Xidong Wang,Huaming Wang,Wenxian Lu,Junyi Guo,Xuhui Zhang,Shaojun Hao,Guoqi Xie,Xiuli Geng,Wenjun Li,Zhengchen Zhang
2019-01-01
Fresenius environmental bulletin
Abstract:Kangxuan Granules (KXG), a traditional Chinese medicine prescription, has been used for treating patients with vertigo. The aim of this study was to investigate the effect of KXG on endocrine hypertensive model rats. SD rats were subcutaneously injected with testosterone propionate to establish endocrine hypertensive animal models. They were treated with KXG (2.5 g/kg, 5 g/kg and 10 g/kg), Yangxue Qingnao (YXQN, 2 g/kg), Captopril (CTP, 12.5 mg/kg) and the same volume of distilled water. The average blood pressure and general behavioral observation of rats were performed before modeling, on 7 and 14 d after modeling and 7 d after drug treatment. Then, after 2 h of medication on the seventh day, angiopoietin-2 (ANG-2), endothelin (ET), superoxide dismutase (SOD), malondialdehyde (MDA), alanine transaminase (ALT), aspartate aminotransferase (AST), triglyceride (TG) and high-density lipoproteincholestero (HDL-C) were detected. The systolic blood pressure (SBP) and diastolic blood pressure (DBP), ANG-II, ET, TG, SOD, MDA, ALT and AST levels were significantly increased, but HDL-C level was decreased in the model group than the normal group. Moreover, KXG added SOD and HDL-C levels, while reduced SBP, SDP, ANG-II, ET, TG, MDA, ALT and AST levels in dose dependent manner. Taken together, our study suggests that KXG has a good effect on endocrine hypertensive rat model.